Sanofi
-
Sanofi(SNY) Q3: EPS 4.02 USD (above forecast), Revenue 16.36B USD (above forecast)
Sanofi(SNY) Q3 EPS: 4.02 USD; Forecast 1.63 USD Revenue: 16.36B USD; Forecast 14.87B USD Reporting period: 2026 Q3 (period ended 2026-09-30) Release date: 2026-10-30
-
Cheplapharm to acquire 20 drugs and three production sites from Sanofi.
Cheplapharm has entered into a strategic partnership with Sanofi, under which Cheplapharm will take over Sanofi's portfolio of 20 mature medicines and three production sites located in Hungary, Singap
-
Antipodes Global Value Strategy Fund divested from Sanofi (SNY) in Q2 2026 due to the underperformance of its R&D pipeline.
Investment firm Antipodes Global Value Strategy disclosed in its Q2 2026 letter to investors that it has exited its position in French pharmaceutical and healthcare company Sanofi (Nasdaq: SNY). The s
-
Sanofi(SNY) Q3: EPS 4.02 USD (above forecast), Revenue 16.36B USD (above forecast)
Sanofi(SNY) Q3 EPS: 4.02 USD; Forecast 1.63 USD Revenue: 16.36B USD; Forecast 14.87B USD Reporting period: 2026 Q3 (period ended 2026-09-30) Release date: 2026-10-30
-
Cheplapharm to acquire 20 drugs and three production sites from Sanofi.
Cheplapharm has entered into a strategic partnership with Sanofi, under which Cheplapharm will take over Sanofi's portfolio of 20 mature medicines and three production sites located in Hungary, Singap
-
Antipodes Global Value Strategy Fund divested from Sanofi (SNY) in Q2 2026 due to the underperformance of its R&D pipeline.
Investment firm Antipodes Global Value Strategy disclosed in its Q2 2026 letter to investors that it has exited its position in French pharmaceutical and healthcare company Sanofi (Nasdaq: SNY). The s
- No data
Sanofi
24H Trending
-
1
ETH (Ethereum) surged 5.31% in 1 hour, currently trading at $2,439.61
-
2
What Elements Are Included in Tokenomics? How to Use It to Identify Valuable Digital Currencies
-
3
Why are various blockchain protocols launching native stablecoins?
-
4
How to buy and sell HERO? First distinguish the project, then check the listing channels
-
5
Cosmos (ATOM) Outlook Analysis: Tokenomics Restructuring and Cross-Chain Upgrades
-
6
CVS Health plans to split into two independent publicly traded companies by early 2028, reversing its $78 billion acquisition of Aetna.
-
7
Where to Find Reliable USDT Trading Software: Top Exchange References and Selection Criteria
-
8
What is DAFI Token? A Comprehensive Guide to DAFI Protocol and Synthetic Token Mechanics
-
9
Why 1WO Price Predictions Are Unreliable: Current Status and Liquidity Analysis of 1World Online
-
10
Current Status and Future Outlook of IMX in Blockchain Gaming
Markets Today
Recommended Reading




